Breast cancer risk is influenced by rare coding variants in susceptibility genes, such as
BRCA1, and many common, mostly non-coding variants. However, much of the genetic …

Breast cancer is the most common cancer among women. Common variants at 27 loci have
been identified as associated with susceptibility to breast cancer, and these account for ∼9…

Background Circulating tumor cells (CTCs) have been shown to predict reduced survival
outcomes in metastatic breast cancer. Methods CTCs were analyzed in 2026 patients with early …

Breast cancer (BC) is the most frequent carcinoma in women. The cumulative risk for the
disease is 10% up to the age of 80 years. A familial history of BC and ovarian cancer (OC) is a …

We show that DNA methyltransferase inhibitors (DNMTis) upregulate immune signaling in
cancer through the viral defense pathway. In ovarian cancer (OC), DNMTis trigger cytosolic …

Stratification of women according to their risk of breast cancer based on polygenic risk scores
(PRSs) could improve screening and prevention strategies. Our aim was to develop PRSs, …

Background Previous studies have suggested that breast cancer risk factors are associated
with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors. …

Purpose The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial (median follow-up,
68 months) has shown that adjuvant anastrozole has superior efficacy and better tolerability …

Background Comprehensive data from prospective clinical trials have led to a high level of
evidence establishing CDK4/6 inhibitors in combination with endocrine treatment (CDK4/6i + …

Purpose: To investigate the proportion of breast cancers arising in patients with germ line
BRCA1 and BRCA2 mutations expressing basal markers and developing predictive tests for …